Page 5 - Discovery Engine News Today

Pfizer discusses license for generic Paxlovid treatment with China; AbbVie spends $30 million upfront for Immunome partnership to bolster antibody research.

WASHINGTON (dpa-AFX) - AbbVie (ABBV) and Immunome Inc. (IMNM) have collaborated to discover up to 10 novel antibody-target pairs arising from three specified tumor types using Immunome's Discovery

/PRNewswire/ -- AbbVie (NYSE: ABBV) and Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biopharmaceutical company that utilizes its human memory B cell...

AbbVie announced a collaboration with clinical-stage biopharma company Immunome to discover as many as 10 novel oncology antibody-target pairs.

NEW HAVEN, Conn., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

Hartford Funds launches new factor-based equity ETF; BenchMine creates free search engine for 401(k) industry plan data; and Corebridge Financial introduces Dimensional Index designed for Power Series of Index Annuities.

ARV-471 continues to show activity in heavily pre-treated patients with locally advanced or metastatic ER+/HER2- breast cancer Median progression free...

– On track to initiate enrollment of two Phase 3 trials with ARV-471 in patients with first- and second-line metastatic breast cancer – – Enrolling...

07.11.2022 - Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced that it is presenting a poster at the Society for ... Seite 1

WIRED spoke with the head of Facebook about competition from TikTok and his theory that algorithms can enhance our personal relationships.